Diagnostic Software
Powerful AIsolutions to advancethe standard of care
Products in development
2 Products
-
Metastasis to nearby lymph nodes significantly impacts the prognosis of breast cancer. We are developing a new algorithm that analyzes the WSI of Sentinel Lymph Nodes to locate small patches of metastases hidden in expansive regions of normal tissue.
Sentinel Lymph Node (SLN)
-
The newest addition to the DeepDx product line, this algorithm identifies and highlights cancerous areas in WSIs of biopsy specimens obtained from TURBT (Trans Urethral Resection of Bladder Tumor)
Bladder
Technological Differentiation
Advanced deep learning technology to provide unmatched precision
Core technology that sets us apart
Our patented methods have been trained on thousands of cases to yield instantaneous and precise analysis of data.
The technological differentiation of
our algorithms stems from world-class patents in:
-
01
Deep learning-based diagnostics
technology -
02
Diagnostic result visualization
technology -
03
Tissue slide indexing technology
-
04
Intelligent annotation technology
Our technology excellence has been proven and acknowledged
-
- Edison Awards - Silver
- DeepDx Prostate, won Silver at the Edison Award 2021 in the Cellular Research & Disease Prevention category.
-
- Camelyon17 Grand Challenge
- Our research team won first place in Camelyon17, a global image analysis competition for detection and classification of breast cancer metastases to lymph nodes.
Deep Bio continues its innovative research and development in medical AI
- Prognoses
- To improve the quality of medical services and reduce costs for patient to only receive the essential examination and treatment that’s right for them, Deep Bio is developing deep learning-based prognosis prediction models based on cancer tissue molecular shape.
- Treatment
- Along with increasing diagnostic precision, Deep Bio uses its AI capabilities to find the most optimized treatment candidates as well as contributes to time and cost savings during the development of new drugs.